View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Paclitaxel 50 / Carboplatin 2 / Radiation, carcinoma esophagus and gastroesophageal junction, neoadjuvant
Protocol-ID: 131 V1.3 (Mini), PACL50/CRBP2/Radiation, Esophageal Ca/AEG, neoadj.Indication(s)
- Esophageal Cancer; ICD-10 C15.-
ST Radiotherapy: Combined radiochemotherapy |
| 41.4 Gy in 23 fractions, 5 days per week. For this, reference is made to the corresponding protocols of radiotherapy. |
Links
- Pharmacokinetics of paclitaxel and carboplatin in a dose-escalating and dose-sequencing study in patients with non-small-cell lung cancer. The European Cancer Centre. [PMID]
- Preoperative chemoradiotherapy for esophageal or junctional cancer. [PMID]
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 13.01.2023